- Home
- VIGL vs SRBK Comparison
VIGL vs SRBK Comparison
Compare VIGL & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- SRBK
- Stock Information
- Founded
- VIGL 2020
- SRBK 1887
- Country
- VIGL United States
- SRBK United States
- Employees
- VIGL N/A
- SRBK N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- SRBK
- Sector
- VIGL Health Care
- SRBK
- Exchange
- VIGL Nasdaq
- SRBK Nasdaq
- Market Cap
- VIGL 134.9M
- SRBK 117.4M
- IPO Year
- VIGL 2022
- SRBK N/A
- Fundamental
- Price
- VIGL $7.96
- SRBK $13.50
- Analyst Decision
- VIGL Buy
- SRBK
- Analyst Count
- VIGL 7
- SRBK 0
- Target Price
- VIGL $8.00
- SRBK N/A
- AVG Volume (30 Days)
- VIGL 1.5M
- SRBK 121.7K
- Earning Date
- VIGL 08-12-2025
- SRBK 07-25-2025
- Dividend Yield
- VIGL N/A
- SRBK 0.37%
- EPS Growth
- VIGL N/A
- SRBK N/A
- EPS
- VIGL N/A
- SRBK N/A
- Revenue
- VIGL N/A
- SRBK $27,988,000.00
- Revenue This Year
- VIGL N/A
- SRBK N/A
- Revenue Next Year
- VIGL N/A
- SRBK N/A
- P/E Ratio
- VIGL N/A
- SRBK N/A
- Revenue Growth
- VIGL N/A
- SRBK 23.80
- 52 Week Low
- VIGL $1.31
- SRBK $9.12
- 52 Week High
- VIGL $7.96
- SRBK $13.65
- Technical
- Relative Strength Index (RSI)
- VIGL 88.44
- SRBK 62.38
- Support Level
- VIGL $7.86
- SRBK $13.00
- Resistance Level
- VIGL $7.90
- SRBK $13.29
- Average True Range (ATR)
- VIGL 0.03
- SRBK 0.20
- MACD
- VIGL -0.20
- SRBK 0.04
- Stochastic Oscillator
- VIGL 91.67
- SRBK 94.52
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About SRBK SR Bancorp Inc. Common stock
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.